Prognostic factors of functional results of surgery for idiopathic (primary) epimacular membranes: cystoid macular edema. Part 2
https://doi.org/10.21516/2072-0076-2020-13-4-105-110
Abstract
The second part of the review (for the first part, see ROJ 2020; 13 (2): 99–104), discusses the dynamics of cystoid macular edema (CME) resorption, macular profile changes after the removal of idiopathic epimacular membranes (EMM), the impact of CME and the macular profile on visual functions of eyes with EMM, and issues of CME management after EMM removal.
About the Authors
S. G. Toropygin
Tver State Medical University
Russian Federation
Russian Federation
Sergei G. Toropygin — Dr. of Med. Sci., assistant professor, head of chair of ophthalmology
4, Sovetskaya St., Tver, 170100
S. V. Nazarova
Tver State Medical University
Russian Federation
Russian Federation
Stanislava V. Nazarova — postgraduate student, chair of ophthalmology
4, Sovetskaya St., Tver, 170100
H. Dawarah
Tver State Medical University
Russian Federation
Russian Federation
Haijan Dawarah — ophthalmologist, chair of ophthalmology
4, Sovetskaya St., Tver, 170100
A. N. Maslov
Tver State Medical University
Russian Federation
Russian Federation
Alexander N. Maslov — assistant professor, the chair of physics, mathematics and medical informatics
4, Sovetskaya St., Tver, 170100
References
1. Maguire A.M., Margherio R.P., Dmuchowski C. Preoperative fluorescein angiographic features of surgically removed idiopathic epiretinal membrane. Retina. 1994; 14 (5): 411–6. doi:10.1097/00006982-199414050-00004
2. Charles S., Calzada J., Wood B. Vitreous microsurgery. Lippincott Williams and Wilkins; 2007.
3. Ducournau D., Ducournau Y., Kuhn F. Surgery for idiopathic epiretinal membrane and macular edema. A new concept based on a personal experience of over 16000 cases. Multimedia interactive book. 2011.
4. Wickham L., Gregor Z. Epiretinal membranes. 5th ed. Los Angeles: 2013; 1954–61. doi.org/10.1016/B978-1-4557-0737-9.00116-8
5. Toropygin S.G. Surgery of thin intraocular structures. Tver: IP Orlova Z.P; 2014 (in Russian).
6. Shahidi M., Ogura Y., Blair N.P., et al. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch. Ophthalmol. 1991; 109: 1115–9. doi:10.1136/bjo.78.11.827
7. Frisina R., Pinackatt S.J., Sartore M., et al. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefes Arch. Clin. Exp. Ophthalmol. 2015; 253 (1): 47–56. doi:10.1007/s00417-014-2655-x
8. Koen S.I., Kvintel' G. Fluorescence angiography in diagnostics of fundus pathology. Тranslation from English. Moscow: Rejtar; 2005 (in Russian).
9. Lumbroso B., Rispoli M. OCT (retina, choroid, glaucoma). Тranslation from English. Mosсow: BINOM; 2014 (in Russian).
10. Fiho C.A., Yehoshua Z., Gregori G., Puliafito C.A., Rosenfeld P.J. Optical coherence tomography. In: Retina Fifth Edition. 2012; 1: 82–110. Elsevier Inc. https://doi.org/10.1016/B978-1-4557-0737-9.00003-5
11. Chan A., Duker J.S., Ko T.H., et al. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch. Ophthalmol. 2006; 124: 193–8. doi:10.1001/Farchopht.124.2.193
12. Kim J., Rhee K.M., Woo S.J., et al. Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane. Am. J. Ophthalmol. 2010; 150(5): 701–9. doi: 10.1016/j.ajo.2010.05.037
13. Mayer W.J., Vogel M., Neubauer A., et al. Pars plana vitrectomy and internal limiting membrane peeling in epimacular membranes: correlation of function and morphology across the macula. Ophthalmologica. 2013; 230: 9–17. doi:10.1159/000350233
14. Massin P., Allouch C., Haouchine B., et al. Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery. Am. J. Ophthalmol. 2000; 130(6): 732–9. doi:10.1016/S0002-9394(00)00574-2
15. Mitamura Y., Mitamura-Aizawa S., Katome T., et al. Photoreceptor impairment and restoration on optical coherence tomographic images. J. Ophthalmol. 2013. Article ID 518170. http://dx.doi.org/10.1155/2013/518170
16. Niwa T., Terasaki H., Kondo M., et al. Function and morphology of macula before and after removal of idiopathic epiretinal membrane. Invest. Ophthalmol. Vis. Sci. 2003; 44(4): 1652–6. doi:10.1167/iovs.02-0404
17. Shimozono M., Oishi A., Hata M., et al. The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am. J. Ophthalmol. 2012; 153 (4): 698–704. doi:10.1016/j.ajo.2011.09.011
18. Suh M.H., Seo J.M., Park K.H., Yu H.G. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal. Am. J. Ophthalmol. 2009; 147(3): 473–80. doi:10.1016/j.ajo.2008.09.020
19. Wilkins J.R., Puliafito C.A., Hee M.R., et al. Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology. 1996; 103 (12): 2142–51. doi:10.1016/S0161-6420(96)30377-1
20. Cho K.H., Park S.J., Cho J.H., et al. Inner-retinal irregularity index predicts postoperative visual prognosis in idiopathic epiretinal membrane. Am. J. Ophthalmol. 2016; 168: 139–49. doi:10.1016/j.ajo.2016.05.011
21. Mitamura Y., Hirano K., Baba T., Yamamoto S. Correlation of visual recovery with presence of photoreceptor inner/outer segment junction in optical coherence images after epiretinal membrane surgery. Br. J. Ophthalmol. 2009; 93(2): 171–5. doi: 10.1136/bjo.2008.146381
22. Bowling B. Kanski's clinical ophthalmology: a systematic approach, 8th edition. Sydney, Australia: Elsevier; 2016.
23. Gass J.D.M. Stereoscopic atlas of macular diseases. Diagnosis and treatment, ed. 3. St. Louis: C.V. Mosby; 1987.
24. Wells J.A. The paradigm shifts in the management of retinal vein occlusion. Retinal Physician. 2011; Nov. 36–40. https://www.retinalphysician.com/issues/2011/nov-dec/the-paradigm-shifts-in-the-management-of-retinal-v
25. Leopold I.H. Nonsteroidal and steroidal anti-inflammatory agents. In: Sears M.L., Tarkkanen A., eds. Surgical pharmacology of the eye. New York: Raven Press; 1985: 83–133.
26. Hattenbach L.O., Springer-Wanner C., Hoerauf H., et al. Intravitreal sustainedrelease steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes. Ophthalmologica. 2017; 237 (4): 232–7. doi: 10.1159/000464259
27. Sella R., Galor O., Goh Y.W., et al. Role of concomitant triamcinolone acetonide injection in small-gauge vitrectomy for idiopathic epiretinal membrane peel. Asia Pas. J. Ophthalmol. (Phila). 2015; 4 (4): 204–7. doi: 10.1097/APO.0000000000000049
28. Ahn J.H., Park H.J., Lee J.E., Oum B.S. Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane. Retina. 2012; 32 (5): 892–6. doi: 10.1097/IAE.0b013e318229b1f7
29. Lai C.C., Wang N.K., Wu W.C., et al. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane. Cutan. Ocul. Toxicol. 2011; 30 (4): 292–7. doi: 10.3109/15569527.2011.568031
30. Taney L.S., Baumal C.R., Duker J.S. Sustained-release dexamethasone intravitreal implant for persistent macular edema after vitrectomy for epiretinal membrane. Ophthalmic Surg. Lasers Imaging Retina. 2015; 46 (2): 224–8. doi: 10.3928/23258160-20150213-01
31. Chen C.H., Wu P.C., Liu Y.C. Intravitreal bevacizumab injection therapy for persistent macular edema after idiopathic macular epiretinal membrane surgery. J. Ocul. Pharmacol. Ther. 2011; 27 (3): 287–92. doi: 10.1089/jop.2010.0166
32. Li Z., Zhang G., Su K., et al. Membrane peeling combined with intravitreal injection of bevacizumab for treatment of macular epiretinal membrane: analysis of 33 cases. Nan. Fang. 2014 Jul; 34 (8): 1207–9. PMID:25176098
33. Lee S.S., Ghosn C., Yu Z., et al. Vitreous VEGF clearance is increased after vitrectomy. Invest. Ophthalmol. Vis. Sci. 2010; 51 (4): 2135–8. doi: 10.1167/iovs.09-3582
34. Aras C., Arici C., Acar S., et al. Peeling of internal limiting membrane during vitrectomy for complicated retinal detachment prevents epimacular membrane formation. Graefes Arch. Clin. Exp. Ophthalmol. 2009; 247 (5): 619–23. doi:10.1007/s00417-008-1025-y
35. Khokhar A.R., Rab K.F., Akhtar H.U. Management of macular pucker. J. Coll. Physicians Surg. Pak. 2003; 13 (12): 701–3. doi: 12.2003/JCPSP.701703
36. Park D.W., Dugel P.U., Garda J., et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology. 2003; 110 (1): 62–4. doi:10.1016/S0161-6420(02)01440-9
37. Chang-Lin J.E., Burke J.A., Peng Q., et al. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest. Ophthalmol. Vis. Sci. 2011; 52 (7): 4605–9. doi: 10.1167/iovs.10-6387
Review
For citations:
Toropygin S.G., Nazarova S.V., Dawarah H., Maslov A.N. Prognostic factors of functional results of surgery for idiopathic (primary) epimacular membranes: cystoid macular edema. Part 2. Russian Ophthalmological Journal. 2020;13(4):105-110. (In Russ.) https://doi.org/10.21516/2072-0076-2020-13-4-105-110
Views:
630
Email this article 